St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Authors
Keywords
-
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 395, Issue 6, Pages 629-642
Publisher
Springer Science and Business Media LLC
Online
2022-03-16
DOI
10.1007/s00210-022-02229-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and Epigenetic Consequence of Early-Life Social Stress on Depression: Role of Serotonin-Associated Genes
- (2021) Tomoko Soga et al. Frontiers in Genetics
- Effects of Selective Serotonin Reuptake Inhibitors on Depression-Like Behavior in a Laser-Induced Shock Wave Model
- (2021) Soichiro Seno et al. Frontiers in Neurology
- Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior
- (2021) Briana K. Chen et al. BIOLOGICAL PSYCHIATRY
- Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
- (2021) Hugo R. Arias et al. MOLECULES
- Hyperforin alleviates the psychiatric disorders of adult rats suffered from early maternal separation via activating autophagy
- (2021) Shengwen Wang et al. NEUROSCIENCE LETTERS
- Study of the Neurotransmitter Changes Adjusted by Circadian Rhythm in Depression Based on Liver Transcriptomics and Correlation Analysis
- (2021) Peng Wang et al. ACS Chemical Neuroscience
- Low Doses of Ketamine and Melatonin in Combination Produce Additive Antidepressant-like Effects in Mice
- (2021) Rosa Estrada-Reyes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression
- (2021) Shami Kanekar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Wait-there’s evidence for that? Integrative medicine treatments for major depressive disorder
- (2021) Stephen J Warnick et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Therapeutic Potential of Curcumin in Reversing the Depression and Associated Pseudodementia via Modulating Stress Hormone, Hippocampal Neurotransmitters, and BDNF Levels in Rats
- (2021) Asia Afzal et al. NEUROCHEMICAL RESEARCH
- Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
- (2021) Shijing Wang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule
- (2021) Adejoke Yetunde Onaolapo et al. World Journal of Psychiatry
- Anxiogenic and anxiolytic effects of memantine injected into the ventral hippocampus in male stressed mice
- (2021) Mohammad Sahraei et al. Journal of Complementary and Integrative Medicine
- Sex differences in the transcription of glutamate transporters in major depression and suicide.
- (2020) Brian Powers et al. JOURNAL OF AFFECTIVE DISORDERS
- Electroconvulsive therapy decreases striatal dopamine transporter binding in patients with depression: A positron emission tomography study with [18F]FE-PE2I
- (2020) Takahiro Masuoka et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- An early increase in glutamate is critical for the development of depression-like behavior in a chronic restraint stress (CRS) model
- (2020) Jing Li et al. BRAIN RESEARCH BULLETIN
- Hypericum perforatum L.: a medicinal plant with potential as a curative agent against obesity-associated complications
- (2020) Hilal Büşra Tokgöz et al. MOLECULAR BIOLOGY REPORTS
- Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor
- (2020) Gudrian Ricardo Lopes de Almeida et al. MOLECULAR NEUROBIOLOGY
- In Vitro Effects of St. John’s Wort Extract Against Inflammatory and Oxidative Stress and in the Phagocytic and Migratory Activity of Mouse SIM-A9 Microglia
- (2020) Gabriel A. Bonaterra et al. Frontiers in Pharmacology
- Anti-Tumor Activity of Hypericum perforatum L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics
- (2020) Marta Menegazzi et al. Antioxidants
- Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: A study of three different doses of 810 nm laser
- (2019) Emad Eshaghi et al. LASERS IN SURGERY AND MEDICINE
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial
- (2019) Alieh Eatemadnia et al. COMPLEMENTARY THERAPIES IN MEDICINE
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
- (2019) Yukio Ago et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like activity of hyperforin and changes in BDNF and zinc levels in mice exposed to chronic unpredictable mild stress
- (2019) Bernadeta Szewczyk et al. BEHAVIOURAL BRAIN RESEARCH
- Enhanced cholinergic-tone during the stress induce a depressive-like state in mice
- (2018) Sara S. Fernandes et al. BEHAVIOURAL BRAIN RESEARCH
- Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2AAntagonist Activity for the Treatment of Depression
- (2018) Xiangqing Xu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Maternal Separation Induces Different Autophagic Responses in the Hippocampus and Prefrontal Cortex of Adult Rats
- (2018) Chunhua Liu et al. NEUROSCIENCE
- Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
- (2018) Jason A. Gandelman et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons
- (2018) Gabriel A. Bonaterra et al. Frontiers in Pharmacology
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Subchronic treatment with St John’s wort produces a positive shift in emotional processing in healthy volunteers
- (2018) Matthew B Warren et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
- (2018) Sho Moriguchi et al. MOLECULAR PSYCHIATRY
- Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice
- (2018) Bartłomiej Pochwat et al. Frontiers in Molecular Neuroscience
- Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
- (2018) Caroline Madeira et al. Frontiers in Psychiatry
- Clinical risks of St John’s Wort (Hypericum perforatum) co-administration
- (2017) Samaneh Soleymani et al. Expert Opinion on Drug Metabolism & Toxicology
- Dopamine System Dysregulation in Major Depressive Disorders
- (2017) Pauline Belujon et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
- (2017) Qin Xiang Ng et al. JOURNAL OF AFFECTIVE DISORDERS
- The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women
- (2017) Maryam Hajhashemi et al. Journal of Maternal-Fetal & Neonatal Medicine
- Adult hippocampal neurogenesis and cognitive flexibility — linking memory and mood
- (2017) Christoph Anacker et al. NATURE REVIEWS NEUROSCIENCE
- Suppression of reward-induced dopamine release in the nucleus accumbens in animal models of depression: Differential responses to drug treatment
- (2017) Saki Minami et al. NEUROSCIENCE LETTERS
- Disruption of the Glutamate–Glutamine Cycle Involving Astrocytes in an Animal Model of Depression for Males and Females
- (2016) Virginie Rappeneau et al. Frontiers in Behavioral Neuroscience
- Spillover of a biological control agent (Chrysolina quadrigemina) onto native St. Johnswort (Hypericum punctatum)
- (2016) Jessica L. Tingle et al. PeerJ
- Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone
- (2015) Tore Bjerregaard Stage et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors
- (2015) Andrea Navarria et al. NEUROBIOLOGY OF DISEASE
- Neuromodulation by acetylcholine: examples from schizophrenia and depression
- (2014) Michael J Higley et al. CURRENT OPINION IN NEUROBIOLOGY
- Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression
- (2014) Michelle J. Chandley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Hypericum Perforatum Decreased Hippocampus TNF-α and Corticosterone Levels with No Effect on Kynurenine/Tryptophan Ratio in Bilateral Ovariectomized Rats
- (2014) Wesam M El-Bakly et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- St. John’s Wort enhances the synaptic activity of the nucleus of the solitary tract
- (2014) Katie M. Vance et al. NUTRITION
- Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L.
- (2014) Jingwei Tian et al. Scientific Reports
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease
- (2013) JC Pereira Jr et al. Clinics
- Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression
- (2013) Daniela Solomon et al. JOURNAL OF AFFECTIVE DISORDERS
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
- (2013) Andrew J Bradley et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin and beyond: therapeutics for major depression
- (2013) P. Blier et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Monoamine neurocircuitry in depression and strategies for new treatments
- (2013) Michel Hamon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evaluation of Antidepressant-Like Activity of Novel Water-Soluble Curcumin Formulations and St. John's Wort in Behavioral Paradigms of Despair
- (2012) S.K. Kulkarni et al. PHARMACOLOGY
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
- (2012) Ronald S. Duman et al. TRENDS IN NEUROSCIENCES
- Interaction of St John’s wort (Hypericum perforatum) with clozapine
- (2011) Annelies C.P. Van Strater et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Hypericum perforatumfor the treatment of premenstrual syndrome
- (2011) Masumeh Ghazanfarpour et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial
- (2011) A. Singer et al. PHYTOMEDICINE
- The neurobiology of anhedonia and other reward-related deficits
- (2011) Andre Der-Avakian et al. TRENDS IN NEUROSCIENCES
- WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression
- (2010) GT Whiteside et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway
- (2010) Yi Chang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Better tolerability of St. Johnʼs wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression
- (2010) Siegfried Kasper et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- St. John's wort may improve some symptoms of attention-deficit hyperactivity disorder
- (2010) H. Niederhofer NATURAL PRODUCT RESEARCH
- Effect of St. John’s wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers
- (2010) H.-P. Lei et al. XENOBIOTICA
- A Hypericum Extract in the Treatment of Depressive Symptoms in Outpatients: An Open Study
- (2010) Jörg Melzer et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria
- (2009) Peng Tu et al. JOURNAL OF NEUROCHEMISTRY
- Long-term effects of St. John's wort (Hypericum perforatum) treatment: A 1-year safety study in mild to moderate depression
- (2009) Axel Brattström PHYTOMEDICINE
- Hypericum perforatumL. (St John's wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment?
- (2009) C. Ruedeberg et al. PHYTOTHERAPY RESEARCH
- Altered Striatal Activation Predicting Real-World Positive Affect in Adolescent Major Depressive Disorder
- (2008) Erika E. Forbes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy Subjects
- (2008) Gregor Hasler et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions
- (2008) Liana Urichuk et al. CURRENT DRUG METABOLISM
- Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
- (2008) Beata Karolewicz et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration
- (2008) Joan B. O'Sullivan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search